LATOYA BONAM: Open Payments
NPI 1386115913 · BELLEVUE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 49 payments from 13 companies in 2025. Trend: 2023 $654 · 2024 $579 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 14 | $204 |
| Novo Nordisk Inc | 12 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| ABBVIE INC. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
| PFIZER INC. | 4 | $67 |
| Inspire Medical Systems, Inc. | 1 | $46 |
| SANOFI-AVENTIS U.S. LLC | 2 | $39 |
| Astellas Pharma US Inc | 1 | $28 |
| Abbott Laboratories | 1 | $23 |
Products named: MOUNJARO, CAPLYTA, Kerendia, JARDIANCE, Wegovy, QULIPTA, PREVNAR 20, INSPIRE.
Industry payments across NE — which companies pay providers there.
